← Back to guidelines
Cardiology16 papers

Extrapyramidal disease

Last edited: 4/16/2026

Overview

Extrapyramidal disease encompasses movement disorders affecting motor function beyond the pyramidal tracts, often associated with medications like neuroleptics but can also occur with selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine 1.

Diagnosis

  • Monitor for symptoms including tremors, rigidity, bradykinesia, and dystonia 1.
  • Evaluate medication history, particularly concurrent use of dopamine receptor antagonists 1.
  • No specific diagnostic tests; clinical assessment is primary 1.
  • Management

  • First-line: Adjust or discontinue offending medications if possible 1.
  • Adjunctive treatments: Anticholinergic agents (e.g., trihexyphenidyl) or benzodiazepines for symptomatic relief 1.
  • Consider dose reduction or switching to alternative SSRIs if fluoxetine is implicated 1.
  • Special Populations

  • Pregnancy: Limited data; cautious use of fluoxetine due to potential extrapyramidal effects 1.
  • Pediatrics: Increased vigilance for extrapyramidal symptoms; consider lower doses and alternative therapies 1.
  • Elderly: Higher risk of adverse effects; careful monitoring and dose adjustment recommended 1.
  • Comorbidities: Patients on concomitant neuroleptics or other dopamine receptor antagonists may have increased risk 1.
  • Key Recommendations

  • Fluoxetine may be associated with extrapyramidal reactions, particularly in patients on concurrent dopamine receptor blocking drugs; monitor closely 1 (Evidence: Moderate).
  • Evaluate and adjust medication regimens, including potential discontinuation of fluoxetine, if extrapyramidal symptoms arise 1 (Evidence: Moderate).
  • In elderly patients, exercise heightened caution due to increased susceptibility to extrapyramidal side effects 1 (Evidence: Moderate).
  • References

    1 Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. The American journal of psychiatry 1995. link

    Original source

    1. [1]
      Fluoxetine and extrapyramidal side effects.Coulter DM, Pillans PI The American journal of psychiatry (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG